Expressions of KAI1/CD82 in colorectal carcinoma and their relationship with clinicopathological characteristics
返回论文页
|更新时间:2023-12-18
|
Expressions of KAI1/CD82 in colorectal carcinoma and their relationship with clinicopathological characteristics
Journal of Chongqing Medical UniversityVol. 36, Issue 1, Pages: 33-36(2013)
作者机构:
1. 江苏省淮阴卫生高等职业技术学校淮安市消化道肿瘤重点实验室,淮安,223300
2. 江苏省苏州卫生职业技术学院病理教研室,苏州,215009
3. 江苏省淮安市肿瘤医院病理科,淮安,223200
4. 南京医科大学基础医学院病理学系,南京,210029
作者简介:
基金信息:
DOI:
CLC:
Published:2013,
扫 描 看 全 文
JI Runyuan, SHI Enyi, WANG Yongshi, et al. Expressions of KAI1/CD82 in colorectal carcinoma and their relationship with clinicopathological characteristics. [J]. Journal of Chongqing Medical University 36(1):33-36(2013)
DOI:
JI Runyuan, SHI Enyi, WANG Yongshi, et al. Expressions of KAI1/CD82 in colorectal carcinoma and their relationship with clinicopathological characteristics. [J]. Journal of Chongqing Medical University 36(1):33-36(2013)DOI:
Expressions of KAI1/CD82 in colorectal carcinoma and their relationship with clinicopathological characteristics
Objective:To investigate expressions of KAI1/CD82 in colorectal carcinoma and their correlation with the metastasis of col-orectal carcinoma. Methods:Tissue microarray and immunohistochemistry were used to detect expressions of KAI1/CD82 in 233 cases of colorectal carcinoma. Results:Positive rate of KAI1/CD82 expression in colorectal carcinoma was 51.5%. Expressions of KAI1/CD82 were not correlated with patients’ sex,age,depth of infiltration and lymphnode metastasis,but were correlated with differentia-tion degrees and Dukes stages(P<0.05). Forward stepwise binary Logistic regression revealed that differentiation was the most signifi-cant influencing factor of KAI1/CD82 expression,Exp(b)=0.431,P=0.038,followed by Dukes stage,Exp(b)=0.363,P=0.043. Expres-sions of KAI1/CD82 were decreased in colorectal carcinoma with poor differentiation and at Dukes D stage. Conclusions:Expressions of KAI1/CD82 are closely correlated with differentiation degrees and stages,which are expected to become a new target for tumor prognosis.